With respect to receptor status, the agreement between the extent of residual microcalcifications and the size of the pathological residual tumor was highest in ER(+) and HER2(−) tumors, and this agreement was slightly higher than that for MRI. This evidence concerns the gene ESR1 and neoplasm.